L-Lysine hydrochloride

盐酸赖氨酸

Report date: 2023/02/21 20:00:25
NME

Base Information

Drug NameL-Lysine hydrochloride
Drug Alias NameL-Lysine monohydrochlorideLysine hydrochloride
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPontocerebellar HypoplasiaFeeding and Eating DisordersMalnutrition +[5] 
Global Approved IndicationsPontocerebellar HypoplasiaFeeding and Eating DisordersMalnutrition
Approved Indications in ChinaPontocerebellar HypoplasiaFeeding and Eating DisordersMalnutrition
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesVanderbilt University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University Medical CenterGuangxi Nanning Yongjiang Pharmaceutical Co LtdGuilin Lijiang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPontocerebellar HypoplasiaFeeding and Eating DisordersMalnutrition +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeB05XB03
Related LinksWikipediaDrugBankKEGG